Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Erra, A.
Right arrow Articles by Marsal, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erra, A.
Right arrow Articles by Marsal, S.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 1123-1124
© 2003 British Society for Rheumatology

Letters to the Editor

Is the recommended dose of leflunomide the best regimen to treat rheumatoid arthritis patients?

A. Erra, C. Tomas, P. Barcelo, M. Vilardell1 and S. Marsal

Unitat de Reumatologia and
1 Servei de Medicina Interna, Hospital General i Universitari Vall d'Hebron, Barcelona, Spain

The first 10% of the full text of this article appears below.

SIR, The aim of this letter is to show our experience in the use of leflunomide (LFN) and express our opinion about the recommended dose [1, 2]. As far as we know, no data exist about a possible association between the loading dose and the presence of adverse events. Any new suggestion about the use of LFN should be appreciated, specially after the safety of this . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
P. Maddison, P. Kiely, B. Kirkham, T. Lawson, R. Moots, D. Proudfoot, R. Reece, D. Scott, R. Sword, A. Taggart, et al.
Leflunomide in rheumatoid arthritis: recommendations through a process of consensus
Rheumatology, March 1, 2005; 44(3): 280 - 286.
[Abstract] [Full Text] [PDF]